26 May 2013
Keywords: ph, iii, corifollitropin, trials, proceed, schedule, dutch
Article | 09 July 2007
Dutch drugmaker Organon says that two out of three Phase III clinical trials with corifollitropin alfa (Org 36286), a new long-acting
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
9 July 2007
24 May 2013
© 2013 thepharmaletter.com